Viking Therapeutics ( VKTX 1.92%) stock is soaring. Two years ago, the share price hovered just above $2. Today, shares trade ...

Amgen's entrant in the weight-loss drug gold rush is called MariTide, and it's currently in phase 2 clinical trials. Thanks ...

Could Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) soon face competition in the lucrative weight-loss drug market? So far, the ...

Shares of Eli Lilly (NYSE:LLY) reached new all-time highs this week, driven by the continued share price and fundamental ...

The final week of May, though shortened by a holiday, is still packed with key earnings reports from various sectors, ...